Lotfi, S. (2022). Identification of Deferasirox as a Potential Carbonic Anhydrase II Inhibitor for Glaucoma treatment via Virtual Screening. Journal of Ophthalmic and Optometric Sciences, 6(1), 28–41. https://doi.org/10.22037/joos.v6i1.42856 (Original work published November 8, 2023)